OSTEOPETROSIS

This adverse event was reported 157 times

OSTEOPETROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALENDRONATE SODIUM AND CHOLECALCIFEROL 19 0.0069
1 NEOSTIGMINE METHYLSULFATE 1 0.0023
2 INTERFERON GAMMA-1B 2 0.0014
3 ZOLEDRONIC ACID 45 0.0011
4 DICLOXACILLIN SODIUM 1 0.0011
5 IBANDRONATE SODIUM 3 0.0010
6 PAMIDRONATE DISODIUM 3 0.0009
7 VECURONIUM BROMIDE 1 0.0007
8 PERPHENAZINE 1 0.0005
9 ETOMIDATE INJECTION 1 0.0005
See all drugs enriched for association with OSTEOPETROSIS

OSTEOPETROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interferon gamma [EPC] 2 0.0014
1 Plasma Volume Expander [EPC] 1 0.0003
2 Calcitonin [EPC] 1 0.0003
3 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
4 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
5 Vitamin D [EPC] 20 0.0001
6 Nitrofuran Antibacterial [EPC] 1 0.0001
7 Parathyroid Hormone Analog [EPC] 6 0.0001
8 Vitamin D3 Analog [EPC] 1 0.0000
9 Progesterone [EPC] 1 0.0000
See all drug classes enriched for association with OSTEOPETROSIS